You are saying the company is not a buy at $2.50 according to his model. But at $2.50 HERB is trading at a P/E of 3 and a P/Book of close to 18%. That's exceptionally cheap, so that is where the model fails.
More so, companies trading at these depressed levels don't want to issue stock and raise cash. They may have trouble getting loans as well. So in this case the current assets relative to non-current assets is very low. Which means the model doesn't work for the depressed China space. At least not in HERB's case.
Let's leave it at that.
Recent HERB News
- Form C-AR - Annual Report • Edgar (US Regulatory) • 02/26/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 08:51:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 07:00:08 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM